Kevin Tyan
10PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Sep 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.Brandon M Huffman, Osama E Rahma, Kevin Tyan
|Jul 03, 2023
Implementation of a novel color additive for bleach disinfectant wipes enhances cleaning performance in an academic medical center.Kevin Tyan, Jason Kang
|Jun 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profiling.Kevin Tyan, Osama Abu-Shawer, Joanna Baginska
|Mar 10, 2022
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors.Osama E Rahma, Kevin Tyan, Anita Giobbie-Hurder
|Dec 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomes.Kevin Tyan, Ji Eun Bae, Jochen H Lorch
|Jan 22, 2021
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors.Kevin Tyan, Joanna Baginska, Martha Brainard
Pageof 2
Frequent Collaborators
1 joint publications
Jeffrey Ishizuka
1 joint publications
Danielle N Margalit
1 joint publications
Roy B Tishler
1 joint publications
Elad Sharon
1 joint publications
Osama Abu-Shawer
1 joint publications
Brandon M Huffman
1 joint publications
Osama E Rahma
1 joint publications
Yvonne Y Li
1 joint publications
Anita Giobbie-Hurder
1 joint publications
Benjamin L Schlechter
